Señales en vivo de COLL | Maximiza tus Ganancias con Getagraph.com

VENDER 104806 min ago

@ $32.43

Emitido: 14 feb 2024 @ 09:32

Retorno: 12.30%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: -1.90 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Stats
Volumen de hoy	121 316
Volumen promedio	410 536
Capitalización de mercado	1.16B
EPS	$0 ( 2024-02-22 )
Próxima fecha de ganancias	( $1.500 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	28.23
ATR14	$0.0310 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-29	Smith Thomas B	Sell	995	Common Stock
2024-02-26	Dreyer Scott	Sell	9 336	Common Stock
2024-02-26	Dreyer Scott	Sell	664	Common Stock
2024-02-12	Tupper Colleen	Buy	30 856	Common Stock
2024-02-12	Tupper Colleen	Sell	16 868	Common Stock

INSIDER POWER
14.83
Last 100 transactions
Buy: 1 331 449 \| Sell: 1 023 987

Volumen Correlación

Largo: 0.07 (neutral)

Corto: -0.21 (neutral)

Signal:(47.312) Neutral

Collegium Pharmaceutical Correlación

10 Correlaciones Más Positivas
BNIXU	0.971
AHCO	0.934
MDRX	0.929
CARA	0.928
RKDA	0.927
ATRA	0.925
CSSE	0.925
DISH	0.924
ETSY	0.923
UPLD	0.922

10 Correlaciones Más Negativas
MSDA	-0.922
MTEK	-0.914
BRIVU	-0.911
VLAT	-0.91
TIOAU	-0.909
ADAL	-0.908
PPYAU	-0.906
NVCN	-0.902
BNIX	-0.902
BRIV	-0.899

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Collegium Pharmaceutical Correlación - Moneda/Commodity

0.59
( weak )

0.60
( weak )

0.00
( neutral )

0.62
( weak )

-0.16
( neutral )

-0.56
( weak negative )

Collegium Pharmaceutical Finanzas

Annual	2023
Ingresos:	$566.77M
Beneficio Bruto:	$326.17M (57.55 %)
EPS:	$1.430

FY	2023
Ingresos:	$566.77M
Beneficio Bruto:	$326.17M (57.55 %)
EPS:	$1.430

FY	2022
Ingresos:	$463.93M
Beneficio Bruto:	$209.49M (45.15 %)
EPS:	$-0.740

FY	2021
Ingresos:	$276.87M
Beneficio Bruto:	$150.62M (54.40 %)
EPS:	$2.05

Financial Reports:

No articles found.

Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Actualizaciones en tiempo real para Collegium Pharmaceutical [COLL]

Upcoming Earnings Alert